Finished
Evaluation of the Use of the Atalante Exoskeleton in Patients Presenting an Hemiplegia Due to Cerebrovascular Accident
NCT04694001 · Wandercraft · Updated 27 April 2022
- What is being tested
- Use of the Atalante exoskeleton
- For
- Stroke; Stroke, Acute; Stroke, Subacute; Chronic Stroke
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 18 years and older. About 40 people. The full rules are on the registry page.
- Where
- Belgium, France, Luxembourg (6 sites)
- When
- Starts or started 12 April 2021, ends 28 March 2022. Registered 5 Jan 2021.
- Results
- None posted yet.
In the researchers' words
The INSPIRE study is interventional, European, prospective, open, multicentric, each patient being his/her own control. It is conducted to assess the safety and performance of the Atalante exoskeleton system in patients presenting an hemiplegia due to cerebrovascular accident. The primary endpoint is defined by the reported adverse events. The study will include 40 patients and takes place in six rehabilitation centers (4 in France, 1 in Luxembourg, 1 in Belgium).
Sites
- Cliniques universitaires Saint-LucBrussels, Belgium
- Centre Jacques Calvé - Fondation HopaleBerck, France
- Centre de Médecine Physique et de RéadaptationPionsat, France
- Centre mutualiste de Rééducation et de Réadaptation de KerpapePloemeur, France
- Hôpital La Musse, La Renaissance SanitaireSaint-Sébastien-de-Morsent, France
- RehazenterLuxembourg, Luxembourg